<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: A comprehensive evaluation of aneurysmal morphometry requires appreciation of both the vascular lumen and the intraluminal <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> imaging methods can both evaluate the lumen and directly image the vessel wall </plain></SENT>
<SENT sid="2" pm="."><plain>We investigated the ability of T1-weighted, T2-weighted, and steady-state <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> imaging techniques to delineate <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> <z:mp ids='MP_0000002'>morphology</z:mp> and reveal changes with time </plain></SENT>
<SENT sid="3" pm="."><plain>MATERIALS AND METHODS: Nine patients with fusiform basilar or intracranial vertebral artery <z:hpo ids='HP_0002617'>aneurysms</z:hpo> that contained intraluminal <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> were studied with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> imaging </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients underwent at least 2 imaging sessions, which were separated by 4-22 months </plain></SENT>
<SENT sid="5" pm="."><plain>Analysis of signal intensity to determine the mean signal intensity from <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e>, blood, CSF, and brain in matched regions was performed </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0002617'>Aneurysm</z:hpo> maximal diameter and cross-sectional area were determined with and without <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">Thrombus</z:e> was identified on <z:hpo ids='HP_0000001'>all</z:hpo> image sequences, and its general appearance was consistent between imaging sessions </plain></SENT>
<SENT sid="8" pm="."><plain><z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">Thrombus</z:e> produced the highest and most consistent signal intensities with T1-weighted and steady-state techniques, though the latter showed superior contrast between <z:chebi fb="2" ids="8069">luminal</z:chebi> blood and <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0001425'>Heterogeneity</z:hpo> within clot was evident in 4/9 of patients, with peripheral hyperintensity being a common feature </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Steady-state imaging was found to be superior to T1- and T2-weighted imaging for delineating and characterizing intraluminal <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> within <z:hpo ids='HP_0002617'>aneurysms</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>The imaging characteristics of intraluminal <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> proved to be very consistent for long periods </plain></SENT>
<SENT sid="12" pm="."><plain>Assessment of overall <z:hpo ids='HP_0002617'>aneurysm</z:hpo> size, including thrombosed portions, permits more accurate evaluation of <z:hpo ids='HP_0002617'>aneurysm</z:hpo> growth and concomitantly may permit more informed clinical decision-making with regard to the timing and need for <z:hpo ids='HP_0002617'>aneurysm</z:hpo> treatment </plain></SENT>
</text></document>